Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

8.66
Delayed Data
As of Jul 31
 +0.20 / +2.36%
Today’s Change
4.26
Today|||52-Week Range
11.15
+14.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line10.4M-35.4M-42.6M4.4M
 
 
 
 
 
Depreciation2.1M1.3M939.0K545.0K
 
 
 
 
 
Total Other Cash Flow6.4M6.2M6.3M7.6M
 
 
 
 
 
Funds From Operations18.8M-27.9M-35.6M11.6M
 
 
 
 
 
Funds From/For Other Operating Expenses422.0K6.7M461.0K-2.2M
 
 
 
 
 
Net Cash Flow - Operating Activities18.4M-34.6M-36.1M13.7M
 
 
 
 
 
 
InvestingDecrease In Investments300.0K100.0K1.1M2.4M
 
 
 
 
 
Capital Expenditures-226.0K-767.0K-137.0K-714.0K
 
 
 
 
 
Fixed Asset Disposal0.00390.0K174.0K143.0K
 
 
 
 
Net Assets From Acquisitions 0.000.001.9M0.00
 
 
Net Cash Flow Investing74.0K-277.0K3.0M1.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale3.7M23.7M40.1M37.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.0045.0K0.00
 
 
Net Cash Flow - Financing3.7M23.7M40.1M37.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash22.2M-11.3M7.0M53.4M